Modern aesthetic practice demands dermal fillers that are predictable, safe, and versatile enough to address a patient's unique anatomical needs. DERMECA hyaluronic acid dermal fillers are designed to meet these demands through a focused R&D approach that prioritizes both clinical performance and patient comfort. The applications for these fillers are comprehensive, encompassing marionette line effacement, chin augmentation to balance facial proportions, and even off label uses such as earlobe rejuvenation and nipple augmentation in post reconstructive surgery. In a clinical evaluation, a cohort of patients treated with DERMECA fillers for lip atrophy reported a high rate of satisfaction, specifically noting the product's smooth texture and the absence of palpable lumps post injection. The foundation of this clinical confidence is TIERA's uncompromising quality system, which is audited and approved under the MDSAP framework, demonstrating compliance with the regulations of the United States, Canada, Australia, and other member countries. The manufacturing process employs closed system tubing and automated filling machines to minimize human intervention and potential contamination, while the final product is tested for critical attributes like swelling factor and injection force. For businesses looking to develop their own brand, TIERA's OEM division offers a full suite of services, from initial concept and formulation tuning to regulatory strategy and final packaging design. Their team can assist in creating a product that stands out in the market, whether through a unique delivery system, a specific combination of hyaluronic acid concentrations, or specialized indication claims. For access to our complete product catalog, detailed OEM service brochure, or to arrange a technical presentation for your clinical team, we encourage you to contact us for a personalized and informative discussion.
Copyright © 2025 by Jiangsu Tiera Biotechnology Co., Ltd